Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

EVIO, Inc. Enters into Agreement to Sell EVIO Labs Portland and Exits US Testing Business

HENDERSON, NV / ACCESSWIRE / May 3, 2022 / EVIO, Inc. (OTC PINK:EVIO) announced today that the company has entered into an asset purchase agreement to sell its Portland Analytical Testing Lab, Greenhaus Analytical Labs LLC dba EVIO Labs Portland, to PREE Laboratories of Corvallis, Oregon.

Under the terms of the agreement, the purchase price of the assets of EVIO Labs Portland is $850,000. The assets include EVIO's customer list, equipment, standard operating procedures, and its cannabis testing license. Closing of the transaction is subject to approval of the Oregon Liquor Control Commission, the government entity that manages the issuances and transfers of cannabis licenses in Oregon. Proceeds from the transaction will be used to pay off all remaining liabilities of the Oregon operations. In addition, EVIO, Inc. has closed C3 Labs, LLC in Berkeley, CA.

As previously disclosed, EVIO's Board of Directors envisions a different future for EVIO Inc. divesting itself of United States based cannabis assets is a major component of the plan. While we believe in the importance of testing cannabis from a consumer safety perspective, the costs to operate and maintain these laboratories continued to far exceed the economic benefit to stakeholders. By vacating the facility in Tigard, OR and the sale of the assets, this will assist in eliminating over $3M in debt on our consolidated balance sheets.

While the company awaits comments back from the SEC, on the Regulation 1-A filing submitted on April 6, 2022, management is continuing efforts bring the financials current and re-attain pink status on OTC Markets.

About EVIO

EVIO, Inc. ("EVIO") is a diversified holding company. Current operations include pharmaceutical, environmental, stability and analytical testing in the US and Canada. EVIO is currently finalizing plans to diversify its business into the mining of precious and rare earth minerals.

For more information, visit www.evioinc.com

Safe Harbor Statement

Any statements in this press release that are not statements of historical fact may be considered forward-looking statements pertaining to anticipated or projected plans, performance, and developments, as well as other statements relating to future operations and results. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only, and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, the Company's ability to complete product testing and launch product commercially, the acceptance of product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in Company reports available at www.evioinc.com.

For more information:
EVIO Inc.
William Waldrop, CEO
Email: info@evioinc.com
Phone (702) 748-9944

SOURCE: EVIO, Inc.



View source version on accesswire.com:
https://www.accesswire.com/699917/EVIO-Inc-Enters-into-Agreement-to-Sell-EVIO-Labs-Portland-and-Exits-US-Testing-Business

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.